Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
As of close of business last night, Annovis Bio Inc’s stock clocked out at $3.78, down -8.47% from its previous closing price of $4.13. In other words, the price has decreased by -$8.47 from its previous closing price. On the day, 0.71 million shares were traded. ANVS stock price reached its highest trading level at $4.2399 during the session, while it also had its lowest trading level at $3.785.
Ratios:
To gain a deeper understanding of ANVS’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.60 and its Current Ratio is at 4.60. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On October 25, 2024, Maxim Group Upgraded its rating to Buy which previously was Hold but kept the price unchanged to $25.
On December 29, 2023, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $36.Canaccord Genuity initiated its Buy rating on December 29, 2023, with a $36 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 08 ’25 when Hoffman Michael B bought 45,000 shares for $4.31 per share. The transaction valued at 193,794 led to the insider holds 2,574,739 shares of the business.
Hoffman Michael B bought 39,200 shares of ANVS for $159,886 on Nov 24 ’25. The Director now owns 2,519,739 shares after completing the transaction at $4.08 per share. On Nov 21 ’25, another insider, Hoffman Michael B, who serves as the Director of the company, bought 20,000 shares for $3.50 each. As a result, the insider paid 69,900 and bolstered with 2,490,539 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ANVS now has a Market Capitalization of 100180912 and an Enterprise Value of 84894520.
Stock Price History:
The Beta on a monthly basis for ANVS is 1.45, which has changed by -0.1917808 over the last 52 weeks, in comparison to a change of 0.12838376 over the same period for the S&P500. Over the past 52 weeks, ANVS has reached a high of $5.60, while it has fallen to a 52-week low of $1.11. The 50-Day Moving Average of the stock is 29.69%, while the 200-Day Moving Average is calculated to be 60.48%.
Shares Statistics:
It appears that ANVS traded 1.82M shares on average per day over the past three months and 1088540 shares per day over the past ten days. A total of 26.50M shares are outstanding, with a floating share count of 22.41M. Insiders hold about 15.28% of the company’s shares, while institutions hold 11.40% stake in the company. Shares short for ANVS as of 1764288000 were 2829273 with a Short Ratio of 1.56, compared to 1761868800 on 1032901. Therefore, it implies a Short% of Shares Outstanding of 2829273 and a Short% of Float of 11.93.
